The Results of Catheter-Based Therapy Compared With Surgical Repair of Adult Aortic Coarctation  by Carr, John Alfred
VT
W
J
C
E
b
m
t
w
e
e
i
t
a
d
M
p
t
b
p
s
i
t
s
i
s
a
a
c
l
c
f
s
c
o
t
C
a
Journal of the American College of Cardiology Vol. 47, No. 6, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
PIEWPOINT
he Results of Catheter-Based Therapy Compared
ith Surgical Repair of Adult Aortic Coarctation
ohn Alfred Carr, MD
hicago, Illinois
A review was performed to compare the results of endovascular therapy (stenting and
angioplasty) with surgical techniques to repair adult aortic coarctation. The immediate
improvement in hypertension and the morbidity were similar across all groups. Surgical
therapy was associated with a very low risk of restenosis and recurrence, whereas endovascular
therapy had a much higher incidence of restenosis and the need for repeat interventions. The
long-term outcome of endovascular approaches will need to be assessed in the future. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.063Coll Cardiol 2006;47:1101–7) © 2006 by the American College of Cardiology Foundation
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dndovascular stenting for thoracic aortic disease is rapidly
ecoming a popular and highly effective way of treating
any complicated conditions, such as aneurysms, dissec-
ions, and penetrating ulcers. In the elderly and frail patients
ith multiple comorbidities who pose a high surgical risk,
ndovascular stenting shows great promise in effectively
liminating potentially lethal conditions with minimal phys-
ologic stress. For this reason, it will no doubt continue to
ake on a larger and more predominant role in the surgical
rmamentarium for those of us who treat thoracic aortic
isease in the elderly.
As pointed out by Lee and White (1) and Fann and
iller (2), the long-term durability of the stent-graft to
revent aneurysm growth, maintain false lumen oblitera-
ion, or penetrate ulcer thrombosis is unknown; however,
ecause the life expectancy of many of these octogenarian
atients is 5 to 7 years, that might be irrelevant. The
hort-term data from several large series of stent-graft
mplantation to treat descending thoracic aneurysms show a
wo-year survival of 73% to 76% and a three-year event-free
urvival of only 53% to 63% (3–6). Considering the debil-
tated condition of most, if not all, of these patients, the
tated results are considered quite acceptable.
The same cannot be said, however, for patients with
ortic coarctation. The majority of these patients are young
nd relatively healthy, with only chronic hypertension as a
omorbidity. Unlike the elderly aneurysm/dissection popu-
ation who need a less-invasive life-saving procedure, the
oarctation population needs a highly durable, lifelong cure
or their hypertension. So what role, if any, does aortic
tent-grafting play in the treatment of native adult aortic
oarctation?
In the last 10 years, there has been an explosion of reports
f endovascular stenting and/or angioplasty of native coarc-
ation in the adult (7–23). Most of these reports cite good
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ccepted October 12, 2005.ngiographic results and a decrease in the transcoarctation
ressure gradient but have very short follow-up and do not
iscuss the most clinically relevant factor: cure of hyperten-
ion. There is strong evidence that a good angiographic
esult after coarctation stenting does not necessarily equate
o a decrease in systemic blood pressure. As noted by Duke
t al. (24), there is a poor correlation between the increase in
he coarctation diameter after stenting and any improve-
ent in hypertension.
There has only been one randomized, multicenter study
omparing angioplasty with surgical repair for coarctation,
nd the results showed higher recurrence rates (50% vs.
1%) and a higher incidence of persistent hypertension
49% vs. 19%) with angioplasty, whereas the complication
ates were similar (25). Nevertheless, there has been a
ramatic increase in the use of this modality, and it is very
imely and important to examine the benefits and risks of
ngioplasty and stenting and compare them with the out-
omes of surgical repair in order to provide the best option
or our patients.
ETHODS
he on-line databases of Medline and PubMed were used
o search for all English language articles related to the
reatment of adult and adolescent coarctation over the last
0 years, 1995 to 2005. See the Appendix for all search
erms used. There were significantly more articles describing
ndovascular results than surgical results. Reports that
ocused on repair in infants and children, review articles,
ditorials, and those that lacked sufficient follow-up infor-
ation or a clear description of what was done were
xcluded from analysis.
For the purposes of this review, mortality was defined as
eath within 30 days of the procedure, as outlined by the
merican College of Surgeons. Morbidity was defined as a
ailure to achieve the desired result or any unplanned or
ntoward event that required another procedure to correct,
id the patient harm, created new pathology that the patient
id not have previously, or increased hospital length of stay.
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Catheter Versus Surgery for Adult Coarctation March 21, 2006:1101–7For all articles, the age, transcoarctation gradients, and
ollow-up are presented as the mean with standard devia-
ion. The morbidity and mortality are listed as a percentage
f the total patients per study as originally presented from
he respective journals. The meta-analysis to determine
ffect size was accomplished with the statistical software
ackage Power and Precision, Version 2 (BioStat Inc.,
nglewood, New Jersey). Logistic regression analysis was
erformed to determine the odds ratios (OR) and 95%
onfidence intervals (CIs) as well as the relative risk (RR)
or the effect of the different therapies on hypertension,
orbidity, restenosis, and repeat interventions. A two-tailed
lpha of 0.05 was used, and the power of each analysis to
etect this significance is presented in the Results section.
In the initial analysis, articles were separated by those that
escribed treating patients with stenting or angioplasty
lone, a combination of stenting and angioplasty, or surgical
herapy. A second analysis attempted to separate patients by
hose with primary versus recurrent coarctation; however,
hereas all of the surgical reports, except one, dealt with
rimary coarctation, the majority of endovascular articles
escribed a mixed patient population of mostly primary,
ith a few recurrent, coarctations. Thus, separation on the
asis of this characteristic was not possible, except for five
ndovascular articles that dealt with a pure patient sample of
rimary coarctation.
Abbreviations and Acronyms
CI  confidence interval
OR  odds ratio
RR  relative risk
able 1. Results of Endovascular Therapy for Coarctation in the
Author (Ref.) Year n
Mean
Age
Initial
Grad Prim
tenting
Suarez de Lezo et al. (7) 2005 73 20 39 53
Johnston et al. (20) 2004 32 20 31 9
Tyagi et al. (13) 2003 21 29 63 0
Harrison et al. (11) 2001 27 30 46 19
Hamdan et al. (14) 2001 34 16 32 13
Cheatham (21) 2001 46 18 45 25
Ledesma et al. (18) 2001 54 22 50 49
Marshall et al. (19) 2000 33 14 25 6
Thanopoulous et al. (12) 2000 17 24 50 8
Ebeid et al. (22) 1997 9 30 37 2
ngioplasty
Fawzy et al. (9) 2004 49 22 66 49
Saba et al. (15) 2000 103 7 59 103
Paddon et al. (16) 2000 17 29 51 17
tenting and angioplasty
Pedra et al. (8) 2005 36 24 57 36
Zabal et al. (10) 2003 54 24 63 54
Macdonald et al. (17) 2003 28 25 34 20
See Table 2 for breakdown of morbidity (Morb), mortality (Mort), and repeat inter
Grad  gradient; Prim  primary coarctation; Recur  recurrent coarctation; Reint
edications for hypertension after therapy.ESULTS
ince 1995, there have been 16 published English-language
eports of the results of endovascular therapy for coarctation
n the adolescent and adult population (Table 1), totaling
33 patients. The mean age was 22 years (SD6.3) with an
verage peak systolic gradient of 47 mm Hg (SD13). The
ean duration of follow-up for these patients was
6 months (SD 23). The morbidity associated with the
tenting procedure ranged from 0% to 20% (mean 9%),
hereas the morbidity for angioplasty was 14% to 24%
mean 19%). Combination therapy of angioplasty and
tenting had a morbidity range of 17% to 22% (mean 19%).
ngioplasty was associated with more complications than
rimary stenting (OR 2.4  CI 0.8, RR 2.1, with 91%
ower). The most common complications in both groups
ere traumatic aneurysm formation at the site of balloon/
tent deployment and aortic dissection (Table 2). No patient
eveloped paralysis. Three of the series reported deaths after
he procedure; however, this occurred too rarely to have
tatistical meaning.
During this same time period, there were six published
eports of the results of surgical therapy for coarctation in
imilar adult populations (Table 3), totaling 213 patients.
he mean age was 37 (SD 15), because the surgical
atients tended to be older than the endovascular cohort
OR 2.1  CI 0.7, RR 1.7 with 99% power). The surgical
atients also had a higher average peak systolic gradient
cross the coarctation (62 mm Hg, SD 6.7) compared
ith both the stenting and angioplasty groups (OR 2.3 
I 0.8, RR 1.5). The mean duration of follow-up for these
atients was 7.8 years (SD 6.5), which was significantly
onger than the endovascular reports. The morbidity asso-
lt
r
Follow-Up
(Months) Morb* Mort* Resten Reinter*
% on
No Med
48 7% 1.3% 10% ? ?
18 6% 0 25% 31% ?
41 5% 0 5% 0 ?
22 19% 0 6% 15% 74%
29 18% 3% 6% 12% 74%
? 20% 0 15% 20% 57%
24 9% 0 ? 7% 56%
27 9% 0 24% 27% 44%
33 0 0 0 0 88%
42 0 0 11% 11% 78%
12 20% 0 8% 10% 63%
18 14% 2% 22% 10% ?
88 24% 0 ? 18% 75%
12 22% 0 11% 6% 66%
43 17% 0 15% ? 41%
79 18% 0 36% 14% 18%
ns.Adu
Recu
20
23
21
8
21
21
5
27
9
7
0
0
0
0
0
8
ventio
er  reintervention; Resten  restenosis; % on No Med  percent receiving no
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March 21, 2006:1101–7 Catheter Versus Surgery for Adult Coarctationiated with the surgical procedures ranged from 0% to 25%
mean 11%), with the most common complications being
leeding and recurrent laryngeal nerve injury (Table 4). No
atient developed paralysis. There was one death across all
f the series.
able 2. Morbidity and Mortality After Endovascular Therapy fo
Author (Ref.) Year n Morbidity
tenting
Suarez de Lezo et al. (7) 2005 73 7% 2 late a
2 ste
Johnston et al. (20) 2004 32 6% 1 dissec
Tyagi et al. (13) 2003 21 5% 1 stent
Harrison et al. (11) 2001 27 19% 3 aneur
1 str
Hamdan et al. (14) 2001 34 18% 1 retrop
ballo
inter
Cheatham (21) 2001 46 20% 2 aneur
dislo
fractu
Ledesma et al. (18) 2001 54 9% 2 aneur
Marshall et al. (19) 2000 33 9% 1 acute
1 fem
trans
Thanopoulous et al. (12) 2000 17 0 None r
Ebeid et al. (22) 1997 9 0 None r
ngioplasty
Fawzy et al. (9) 2004 49 20% 4 aneur
20
surge
Saba et al. (15) 2000 103 14% 8 aneur
arter
1 un
Paddon et al. (16) 2000 17 24% 1 aneur
disse
false
tenting and angioplasty
Pedra et al. (8) 2005 36 17% 1 aneur
fractu
trans
Zabal et al. (10) 2003 54 17% 2 aneur
and 1
1 hem
Macdonald et al. (17) 2003 28 18% 1 dissec
reste
“Cardiac death” after procedure. †1 patient with adult respiratory distress syndrome
MI  myocardial infarction; TIA  transient ischemic attack.
able 3. Results of Surgical Therapy for Coarctation in the Adul
Author (Ref.) Year n
Mean
Age
Initial
Grad Prim Rec
arr et al. (26) 2005 45 21 51 39 6
auer et al. (27) 2001 15 54† 68 15 0
hat et al. (28) 2001 84 29 60 84 0
ouchart et al. (29) 2000 35 28 62 35 0
ris et al. (50) 1999 8 58‡ 70 8 0
ells et al. (51) 1996 26 32 61 26 0
See Table 4 for breakdown of morbidity (Morb), mortality (Mort), and repeat interve
lder cohort (age range 51 to 73 years at time of repair).
Abbreviations as in Table 1.In a comparison of morbidity, primary stenting had the
owest risk of complications, surgery had a slightly higher
isk (OR 1.3  CI 0.2, RR 1.2), and isolated angioplasty
ad a significantly higher risk (OR 2.4  CI 0.9, RR 2.1
ith 84% power).
arctation in the Adult
Mortality Reinterventions
sms, 1 residual stenosis,
grations
1%* ?
1 stent migration 0 10 repeat angioplasties
lized 0 0
and 1 requiring surgery,
failure
0 1 angioplasty,
3 aneurysms
neal hematoma, 1 embolized
stent migration, 1 failed
n requiring surgery
3%† 4 patients, 2 referred to
surgery
2 stents embolized, 1 stent
1 hemothorax, 1 stent
failures
0 5 additional stents,
4 angioplasties
0 4 patients, 2 referred to
surgery
1 cardiac arrest,
thrombosis (7 blood
s)
0 1 stent migration,
8 angioplasties
d 0 0
d 0 1 repeat angioplasty
4 late gradients
Hg, 1 dissection requiring
femoral thrombosis
0 4 repeat angioplasties
1 aneurysm sent to
surgery
1 dissection, 4 femoral
ries requiring surgery,
sful intervention
2%‡ 6 patients sent to
surgery
4 angioplasties
equiring surgery, 1 iliac
1 TIA, 1 misdiagnosed
ysm
0 2 aneurysms referred to
surgery
1 iliac dissection treated
with stent
2 stent migrations, 1 stent
redilation, (2 blood
s), 1 arm infection
0 1 aneurysm, 1 stent
fracture
3 unsuccessful interventions
iring surgery, 3 restenoses,
age at puncture site
0 ?
1 misplaced stent, 3 early 0 4 repeat angioplasties
tracranial bleed, 1 unknown.
Follow-Up
(yrs) Morb* Mort* Resten Reinter*
% on
No Med
18 18% 0 2% 0 76%
4 0 0 0 0 13%†
5 7% 1% 2% 2% 69%
14 9% 0 9% 0 66%
4 25% 0 0 0 63%
2 4% 0 0 0 46%
†Significantly older cohort (age range 50 to 63 years at time of repair). ‡Significantlyr Co
neury
nt mi
tion,
embo
ysms
oke, 1
erito
on, 1
ventio
ysms,
dged,
re, 2
ysms
MI,
oral
fusion
eporte
eporte
ysms,
mm
ry, 1
ysms,
y inju
succes
ysm r
ction,
aneur
ysm,
re, 1
fusion
ysms,
requ
orrh
tion,
nosest
ur
ntions.
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Catheter Versus Surgery for Adult Coarctation March 21, 2006:1101–7After stenting, the restenosis rates ranged from 0% to
5% (mean 11%), whereas the results for angioplasty and
he use of both therapies were 8% to 22% (mean 15%) and
1% to 36% (mean 21%), respectively. This led to repeat
nterventions in the stenting, angioplasty, and combination
roups in 0% to 31% (mean 14%), 10% to 18% (mean 13%),
nd 6% to 14% (mean 10%) of the patients, respectively.
he most common reinterventions were repeat angioplasties
or recurrent stenoses, additional stenting for migrations or
issections, and referral to surgery for traumatic aneurysm
epair. There was no statistically higher incidence or in-
reased risk of needing a reintervention for one method over
he others.
After surgery, the restenosis rates ranged from 0% to 9%
mean 2%). There was a significantly higher risk of reste-
osis after stenting compared with surgery (OR 6.0  CI
.8, RR 5.5) and after angioplasty compared with surgery
OR 8.6  CI 2.2, RR 7.5; both with 96% power). Repeat
nterventions were necessary in only 0.3% of the surgery
atients. There was a dramatically higher risk of needing
epeat interventions after stenting or angioplasty compared
ith surgery (stenting: OR 16.1  CI 2.8, with an RR of
4; angioplasty: OR 14.8  CI 2.7, with an RR of 13; with
5% power) (Fig. 1).
Table 4. Morbidity and Mortality After Surgic
Author (Ref.) Year n Morbidity
Carr et al. (26) 2005 45 18% 3 pos
1 v
pa
nu
Bauer et al. (27) 2001 15 0
Bhat et al. (28) 2001 84 7% 4 pos
2 tra
Bouchart et al. (29) 2000 35 9% 1 pos
2 rec
Aris et al. (50) 1999 8 25% 1 pul
1 atr
Wells et al. (51) 1996 26 4% 1 voc
*1 post-operative (postop) bleeding.
v-tach  episodic ventricular tachycardia in a 53-year-oldsFigure 1. Odds ratios with 95% confidence intervals.Endovascular stenting led to a cure of hypertension
patients no longer requiring any medication to treat hyper-
ension) in 18% to 88% (mean 61%), although four authors
id not report their eventual effect on the patient’s blood
ressure. Surgery led to a cure of hypertension in 13% to
6% (mean 64%) of the patients, although the one series
ith the lowest cure rate (13%) was in a significantly older
ohort of patients with a mean age of 54 years. Because the
ollow-up in the surgical series was much longer than in the
ndovascular reports, comparing the incidence of (or lack of)
ypertension during follow-up between the two groups is
ignificantly skewed.
ISCUSSION
he common rationale for avoiding surgical repair is to
revent postoperative pain and “surgical morbidity”—an
verused term, often invoked as a legitimate reason for
voiding every type of surgery, even those with extremely
ow morbidity, such as coarctation repair. In fact, the true
orbidity of surgical coarctectomy is quite low and is
ctually better than that reported for stenting in several
eries (26–29). In the current analysis, stenting did have a
lightly lower morbidity than surgery, although angioplasty
as higher. Rokkas et al. (30) reported zero mortality and
inimal morbidity in his surgical series, even with compli-
ated coexisting arterial abnormalities and the use of circu-
atory arrest. Bauer et al. (27) reported zero mortality and
orbidity after coarctation repair in a series of complicated
lder adults with an age range of 50 to 63 years. Since 1945,
hen Crafoord et al. (31) reported the very first series of
dolescents and young adults undergoing coarctation repair,
he surgical techniques have continually improved and the
esults have continued to get better. We now have outstand-
ng results with follow-up in several long-term series report-
ng cures of hypertension persisting 18 to 44 years after
urgical repair (26,32–34). It had been previously believed
hat hypertension persisted in the adult after coarctation
epair, but three recent studies have shown that, after
urgery, 58% to 76% of patients will be cured of hyperten-
erapy for Coarctation in the Adult
Mortality Reinterventions
leeding, 1 v-tach,
itis, 1 vocal cord
, 1 transient hand
ss, 1 lymphocele
0 0
0 0
leeding
lower leg weakness
1%* 2 angioplasties
leeding
t nerve injuries
0 0
ry edema
rillation
0 0
d paralysis 0 0
was medically controlled.al Th
top b
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ralysis
mbne
top b
nsient
top b
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al corion and medication-free (26,35,36). On the basis of the
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March 21, 2006:1101–7 Catheter Versus Surgery for Adult Coarctationimited follow-up of 2 to 3 years available for endovascular
epair, it is premature to state that the results are similar to
urgery.
The majority of surgical complications, when they did
ccur, were minor (i.e., vasculitis, bleeding), whereas the
ajority of endovascular complications could be considered
ore severe (i.e., dissection, traumatic aneurysm, stroke). In
he past 10 years, there have not been any reports of
ermanent paralysis, stroke, or cardiac death after surgical
epair (26–30,33,37). There was only one death reported
fter surgery, the result of postoperative hemorrhage. After
ndovascular repair, there were deaths reported (12,19,20).
n addition, endovascular techniques are not without the
isk of paraplegia, which has been reported after angioplasty
f an aortic coarctation (38). Case reports have documented
myriad of complications after coarctation stenting, includ-
ng antegrade dissection, stent collapse, delayed retrograde
issection, restenosis, and even free aortic rupture (39–43).
hus, surgery for aortic coarctation is safer than stenting.
One of the more common complications after stenting is
raumatic aneurysm formation. This is because the method
f aortic enlargement with angioplasty or stenting is by
racturing the intima and media of the aortic wall at the site
f coarctation as well as the surrounding normal tissue (44).
he torn portion of the aortic wall is then only held together
y the adventitia and is prone to dilate over time. We know
rom histologic studies of coarctectomy specimens excised at
urgery or acquired from autopsies that the aortic wall in
his area is always affected by cystic medial necrosis, severely
o in 67% of specimens (45). This structural defect, as well
s accelerated apoptosis in the area after angioplasty, further
ecreases the integrity of the aortic wall and predisposes to
neurysm formation (45,46). It has been hypothesized that
tenting would cover this weakened area and thereby pre-
ent aneurysm formation (44); however, owing to the large
umber of reports documenting aneurysm formation after
tenting, this does not appear to be true (12–16,20,21,23).
hat is the fate of these aneurysms? Do they continue to
nlarge? The current follow-up is not long enough to say,
nd there have been no reports documenting the natural
istory of these unnatural aneurysms. It is only fair to say
hat not all surgical interventions, if any, are followed by
ost-procedural angiography, whereas all catheter-based
nterventions are. Therefore, excessive patch redundancy,
nsufficient patch width, or other technical errors will not be
etected as often immediately after surgical intervention.
Another common—and concerning—complication is the
resence of a residual gradient after stenting. Even mild
esidual stenoses with low but persistent gradients have been
hought to increase the risk of cardiovascular events, such as
ersistent hypertension and decreased left ventricular func-
ion (47–49). Zabal et al. (10) showed that the residual
radient was the most important risk factor for having a
ardiovascular event during follow-up. A residual gradient
f 10 mm Hg was shown to be the best cutoff point for peparation of high and low risk, with a hazard ratio of 9.6
hen compared with a residual gradient of 10 mm Hg.
This makes intuitive sense, because a residual gradient is
ikely to get even higher with exercise. None of the patients
n any of the endovascular series for native coarctation were
xercise-tested after endografting, and so it is unknown if
hey, in fact, have exercise-induced hypertension. The
uthors of two surgical series did perform exercise testing in
heir patients after operation and found a significant inci-
ence of exercise-induced hypertension (defined as systolic
lood pressure 195 mm Hg or higher than the 95th
ercentile for their age and gender) in patients who were
ormotensive at rest (27,29). This is known to be another
isk factor for the eventual development of left ventricular
ysfunction and heart failure. Two studies have shown that
1% to 35% of post-coarctectomy patients with normal
lood pressure at rest demonstrated exercise-induced hyper-
ension, which they defined as systolic blood pressure 200
m Hg (20,29). Thus, exercise testing becomes critical in
ny patient with a mild post-intervention gradient because
ts true effect might be unknown until the patient is fully
ctive.
What might be most concerning is that the one endo-
ascular series with the longest follow-up of more than 6
ears, Macdonald et al. (17), reported a 36% restenosis rate
nd that only 18% of the patients were no longer being
edicated for hypertension. The other series with long-
erm follow-up, Paddon et al. (16), did not report a
estenosis rate and, although only 5 of the 16 patients in that
eries were taking antihypertensive medication before inter-
ention, 4 were still taking medication afterwards. This
bviously creates concern that most of these patients might
e found to have a recurrence or stenosis in the future and
ot only require a second, potentially complicated, interven-
ion but also suffer the effects of undiagnosed hypertension
or several months to years.
Because the entire reason for intervening in patients with
oarctation is to relieve the pathologic hypertension, this is
he most crucial end point to examine. In most surgical
eries there is a consistent cure of hypertension in more than
0% of the patients (26,28,29,36,50,51). This is also a
urable cure, with persistence in the maintenance of nor-
otension in excess of 20 years or more (26,32–34). This
akes it difficult to accept 40% to 60% cure rates after only
to 3 years of follow-up in several endovascular series
10,18,19,21).
To prevent recurrence, it logically makes sense that
tenting would have better results than angioplasty, but this
as not been shown to be true (19–23). The morbidity,
ortality, and repeat intervention rates were just as high for
tenting as they were for angioplasty or using a combination of
oth modalities. Although stenting protects against imme-
iate recoil of the vessel, the long-term results were plagued
y intimal hyperplasia that developed within the stent itself,
eading to recurrence (12,15,17,19–23). This becomes es-
ecially important when one considers the cost-effectiveness
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Catheter Versus Surgery for Adult Coarctation March 21, 2006:1101–7f catheter-based therapies compared with surgery. Surgery
as an extremely low incidence of recurrence, and although
t initially costs more than endovascular approaches, the cost
avings of endovascular therapy only apply if the repeat
nterventions are kept to a minimum (49).
There are a few limitations to this study. In such a pooled
nalysis, there is an inherent selection bias and heteroge-
eous patient mix. This cannot be overcome. In the absence
f a prospective randomized trial, which would be very
ifficult, owing to the low incidence of adults with coarcta-
ion, exact patient matching and equalization of risk factors
s not possible. The assumption is made that all complica-
ions were mentioned in each respective paper and that the
eporting of untoward events and misadventures was hon-
stly upheld by each author.
onclusions. Primary angioplasty or stenting of native
dult aortic coarctation has similar but not less morbidity
han surgical repair. Recurrence and reintervention rates are
uch higher after endovascular therapy. Both therapies
eem to provide relief of hypertension with similar efficacy,
t least in the short term; however, clinical equipoise does
ot currently exist between the two approaches and may not
ntil the long-term outcome of stenting is discovered.
eprint requests and correspondence: Dr. John Alfred Carr,
epartment of Cardiovascular and Thoracic Surgery, University of
hicago, E-500, 5841 South Maryland Avenue, Chicago, Illinois
0637. E-mail: heartandbones@yahoo.com.
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PPENDIX
earch terms used:
oarctectomy
oarctation AND adolescent
oarctation AND adult
oarctation AND surgery
oarctation AND angioplasty
oarctation AND stent
oarctation repair
